More on CUE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cue Biopharma Inc. (NQ:CUE)
Delayed: 0.30 +0.01 (3.45%)
Prev. Close $0.29  
Open$0.30 
52 Wk High$ 
52 Wk Low$ 
Day High$0.30 
Day Low$0.29 
P/E N/A  
EPS$ 
Volume601,270 

Friends, Peers and Foes (?): ACET, ACRV, ARVN, AZN, BCAB (more...)

Mar 6, 2026 04:00 PM Form PRE 14A Cue Biopharma, Inc. For: Mar 06
Feb 18, 2026 04:00 PM Form 8-K Cue Biopharma, Inc. For: Feb 18
Feb 17, 2026 08:00 AM Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
Feb 12, 2026 08:02 AM Cue Biopharma names Lucinda Warren as chief financial and business officer
Feb 12, 2026 08:01 AM Form 8-K Cue Biopharma, Inc. For: Feb 09
Feb 12, 2026 08:00 AM Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
Jan 6, 2026 04:00 PM Form 4 Cue Biopharma, Inc. For: Jan 02 Filed by: Broadfoot Jill Marie
Jan 6, 2026 04:00 PM Form 4 Cue Biopharma, Inc. For: Jan 02 Filed by: Kiener Peter A
Jan 6, 2026 04:00 PM Form 4 Cue Biopharma, Inc. For: Jan 02 Filed by: Garzone Pamela
Jan 6, 2026 04:00 PM Form 4 Cue Biopharma, Inc. For: Jan 02 Filed by: Sarraf Pasha
View All Articles

Entities mentioned with CUE

View All Entities